Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-18T03:24:17.974Z Has data issue: false hasContentIssue false

The effect of low doses of long chain n-3 PUFA intake on sleep-time heart rate variability

Published online by Cambridge University Press:  12 April 2013

G. Hay
Affiliation:
King's College London, Diabetes & Nutritional Sciences Division, Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH,
T. A. B. Sanders
Affiliation:
King's College London, Diabetes & Nutritional Sciences Division, Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH,
P. T Seed
Affiliation:
Women's Health Division, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK
P. J. Chowienczyk
Affiliation:
Cardiovascular Division, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK
W. L. Hall
Affiliation:
King's College London, Diabetes & Nutritional Sciences Division, Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH,
Rights & Permissions [Opens in a new window]

Abstract

Figure 0

Table 1.Treatment effect versus placebo (average of change following each treatment divided by change on placebo at 6 and 12 months), based on estimated marginal means (adjusted for covariates: age, sex, ethnicity, BMI, and the value at baseline).*Placebo (n 52), ref. 1.000. The P value is derived from a linear trend test based on a weighted combination (0:1:2:4) Geometric means (95% CI) on placebo at baseline and follow-up were: SDNN baseline 95.0 (86.8, 103.9) ms, follow-up 87.7 (81.4, 94.6) ms, Ti baseline 21.6 (19.4, 24.1), follow-up 20.0 (18.5, 21.6), HF baseline 324 (260, 404) ms2, follow-up 347 (275, 439) ms2, SDANN baseline 76.3 (68.0, 85.6) ms, follow-up 67.2 (61.0, 74.0) ms, VLF baseline 5363 (4493, 6403) ms2, follow-up 4444 (3844, 5138) ms2